Alert

Alert Pro Chart

SELLAS Life Sciences Grou... (SLS)

NasdaqCM: SLS · Real-Time Price · USD

12.36

+0.59 (5.01%)

At close: Aug 13, 2026, 3:59 PM

12.45

+0.72%

Pre-market: 7:27 AM

Statistics

Share Statistics

SELLAS Life Sciences has 201.95M shares outstanding. The shares have a market value of 2.5B.

Shares Outstanding	201.95M
Shares Change (YoY)	78.18%
Shares Change (QoQ)	n/a
Owned by Institutions (%)	31.89%
Shares Floating	198.86M
Failed to Deliver (FTD) Shares	11,800
FTD / Avg. Volume	n/a

Short Selling Information

Short interest in SELLAS Life Sciences is 27.96% of the outstanding shares, representing 54.98M shares. The short ratio is 6.31.

Short Interest	54.98M
Short % of Shares Out	27.96%
Short % of Float	28.07%
Short Ratio (days to cover)	6.31

Valuation Ratios

PE Ratio	n/a
Forward PE	-123.6
PS Ratio	n/a
Forward PS	47.01
PB Ratio	20.88
P/FCF Ratio	-88.62
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The enterprise value is 2.36B. Enterprise value adds debt and subtracts cash from the company's market cap, providing an alternative valuation for the company.

EV / Sales	n/a
EV / EBITDA	-74.96
EV / EBIT	-83.74
EV / FCF	-83.74

Financial Position

SELLAS Life Sciences's current ratio is 18.83. A current ratio above 1 means that the company has enough short-term assets to cover its short-term liabilities.

Current Ratio	18.83
Quick Ratio	18.28
Debt / Equity	0.01
Debt / EBITDA	-0.03
Debt / FCF	-0.03
Interest Coverage

Financial Efficiency

Return on Equity is -39.63%, and return on invested capital is -29.06%.

Return on Equity	-39.63%
Return on Assets	-23.3%
Return on Invested Capital	-29.06%
Revenue Per Employee	n/a
Profits Per Employee	$-2.27M
Employee Count	13
Asset Turnover	0
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by 658.28% in the past year.

Beta	2.49
52-Week Price Change	658.28%
50-Day Moving Average	10.95
200-Day Moving Average	5.78
Relative Strength Index (RSI)	58.23
Average Volume (20 Days)	9,244,532

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-31.46M
Net Income	-29.46M
EBITDA	-31.46M
EBIT	-31.46M
Earnings Per Share (EPS)	-0.22

Full Income Statement

Balance Sheet

SELLAS Life Sciences has 107.1M in cash on the balance sheet. Total assets are 114.18M, and total liabilities are 871K.

Cash & Cash Equivalents	107.1M
Total Debt	871K
Net Cash	106.23M
Retained Earnings	-283.39M
Total Assets	114.18M
Working Capital	104.71M

Full Balance Sheet

Cash Flow

SELLAS Life Sciences's operating cash flow was -28.16M over the trailing twelve months.

Operating Cash Flow	-28.16M
Capital Expenditures	n/a
Free Cash Flow	-28.16M
FCF Per Share	-0.139

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	0%
Earnings Yield	-1.78%
FCF Yield	-1.13%

Dividend Details

Analyst Forecast

Price Target	$27.5
Price Target Difference	122.49%
Analyst Consensus	n/a
Analyst Count	2

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the fair value of a stock, including the Graham Number and Lynch Fair Value methods.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The most recent stock split was a reverse 1:50 split that occurred on Nov 8, 2019.

Last Split Date	Nov 8, 2019
Split Type	reverse
Split Ratio	1:50

Scores

Altman Z-Score	218.1
Piotroski F-Score	3